Sweet Night (Musical Diffusion by Caregivers ): Effects of Musical Diffusion by Caregivers on Sleep Onset and Behavioral Regulation in a Protected Living
Condition(s) studied
Investigational drug(s) / intervention(s)
Music intervention - passive listening: Diffusion of familiar music in the bedrooms and living room before bedtime; passive and individual listening.
Audio books intervention - active listening: Dynamic audio book listening, akin to active listening while respecting the rhythm of the evening . This type of listening involves concentrating specifically .
Study summary
As the Alzheimer's disease progresses, caregivers and family members often focus on behavioral difficulties. In response to crises, immediate actions tend to favor restraints, either through medication or physical means. This work aims to improve the management of behavioral disturbances in patients with Alzheimer's disease through musical interventions (group or individual), particularly in advanced stages of the disease, where medical and family resources are insufficient. The investigators approach prioritizes NTM over medication as a mean to improve patient well-being. To this end, they have designed a study. The study focuses on creating a conducive environment for sleep by incorporating ritualized, familiar music sessions supervised by nursing staff after meals. To conduct this study, the actigraphy will be used to analyze participants' behavior both day and night, complemented by questionnaires and clinical observations.
Eligibility
Primary outcome measure(s)
- Sleep duration — Days 1 to 51
Sleep duration will be measured by actigraphy (bracelet worn by the participants).
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| CHU de Saint-Etienne | Saint-Etienne | France | Recruiting |
More Centre Hospitalier Universitaire de Saint Etienne trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07207642 on ClinicalTrials.gov ↗ ← All trials in France